Fusion gene information | Fusion gene name: FASN-NRXN3 |
Fusion gene ID: hg2194tg9369 | | Hgene | Tgene | Gene symbol | FASN | NRXN3 | Gene ID | 2194 | 9369 | Gene name | fatty acid synthase | neurexin 3 |
Synonyms | FAS|OA-519|SDR27X1 | C14orf60 |
Cytomap | ('FASN')('NRXN3') 17q25.3 | 14q24.3-q31.1 |
Type of gene | protein-coding | protein-coding |
Description | fatty acid synthaseshort chain dehydrogenase/reductase family 27X, member 1 | neurexin 3neurexin IIIneurexin-3-alpha |
Modification date | 20200329 | 20200313 |
UniProtAcc | . | . |
Ensembl transtripts involved in fusion gene | ENST00000306749, ENST00000579758,
| |
Fusion gene scores | * DoF score | 11 X 12 X 6=792 | 13 X 12 X 3=468 |
# samples | 11 | 16 |
** MAII score | log2(11/792*10)=-2.84799690655495 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(16/468*10)=-1.54843662469604 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 |
Context | PubMed: FASN [Title/Abstract] AND NRXN3 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | FASN(80036321)-NRXN3(79757005), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FASN | C0025202 | melanoma | 3 | CTD_human |
Hgene | FASN | C2239176 | Liver carcinoma | 3 | CTD_human |
Hgene | FASN | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
Hgene | FASN | C0678222 | Breast Carcinoma | 2 | CTD_human |
Hgene | FASN | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Hgene | FASN | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | FASN | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Hgene | FASN | C0006826 | Malignant Neoplasms | 1 | CTD_human |
Hgene | FASN | C0007193 | Cardiomyopathy, Dilated | 1 | CTD_human |
Hgene | FASN | C0007194 | Hypertrophic Cardiomyopathy | 1 | CTD_human |
Hgene | FASN | C0018801 | Heart failure | 1 | CTD_human |
Hgene | FASN | C0018802 | Congestive heart failure | 1 | CTD_human |
Hgene | FASN | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | FASN | C0020796 | Profound Mental Retardation | 1 | CTD_human |
Hgene | FASN | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
Hgene | FASN | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Hgene | FASN | C0023827 | liposarcoma | 1 | CTD_human |
Hgene | FASN | C0025363 | Mental Retardation, Psychosocial | 1 | CTD_human |
Hgene | FASN | C0027651 | Neoplasms | 1 | CTD_human |
Hgene | FASN | C0028754 | Obesity | 1 | CTD_human |
Hgene | FASN | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Hgene | FASN | C0086692 | Benign Neoplasm | 1 | CTD_human |
Hgene | FASN | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Hgene | FASN | C0205824 | Liposarcoma, Dedifferentiated | 1 | CTD_human |
Hgene | FASN | C0205825 | Liposarcoma, Pleomorphic | 1 | CTD_human |
Hgene | FASN | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Hgene | FASN | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
Hgene | FASN | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | FASN | C0917816 | Mental deficiency | 1 | CTD_human |
Hgene | FASN | C0919267 | ovarian neoplasm | 1 | CTD_human |
Hgene | FASN | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
Hgene | FASN | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Hgene | FASN | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | FASN | C1370889 | Liposarcoma, well differentiated | 1 | CTD_human |
Hgene | FASN | C1449563 | Cardiomyopathy, Familial Idiopathic | 1 | CTD_human |
Hgene | FASN | C1959583 | Myocardial Failure | 1 | CTD_human |
Hgene | FASN | C1961112 | Heart Decompensation | 1 | CTD_human |
Hgene | FASN | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | FASN | C3714756 | Intellectual Disability | 1 | CTD_human |
Hgene | FASN | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | FASN | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Hgene | FASN | C4551472 | Hypertrophic obstructive cardiomyopathy | 1 | CTD_human |
Tgene | | C0001973 | Alcoholic Intoxication, Chronic | 1 | PSYGENET |
Tgene | | C0004352 | Autistic Disorder | 1 | GENOMICS_ENGLAND |
Tgene | | C0013146 | Drug abuse | 1 | CTD_human |
Tgene | | C0013170 | Drug habituation | 1 | CTD_human |
Tgene | | C0013222 | Drug Use Disorders | 1 | CTD_human |
Tgene | | C0029231 | Organic Mental Disorders, Substance-Induced | 1 | CTD_human |
Tgene | | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | | C0038580 | Substance Dependence | 1 | CTD_human |
Tgene | | C0038586 | Substance Use Disorders | 1 | CTD_human |
Tgene | | C0236969 | Substance-Related Disorders | 1 | CTD_human |
Tgene | | C0740858 | Substance abuse problem | 1 | CTD_human |
Tgene | | C0853193 | Bipolar I disorder | 1 | PSYGENET |
Tgene | | C1510472 | Drug Dependence | 1 | CTD_human |
Tgene | | C1510586 | Autism Spectrum Disorders | 1 | GENOMICS_ENGLAND |
Tgene | | C4316881 | Prescription Drug Abuse | 1 | CTD_human |